6 results  1 of 1 

1 Talazoparib versus Chemotherapy in Patients with HER2-Negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial
Kyung-Hun Lee, Joohyuk Sohn, Annabel Goodwin, Tiziana Usari, Silvana Lanzalone, Seock-Ah Im, Sung-Bae Kim
Cancer Res Treat.2021;53(4):1084-1095.   Published online 2021 March 24     DOI: http://dx.doi.org/10.4143/crt.2020.1381
      
2 Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea
Se Ik Kim, Maria Lee, Hee Seung Kim, Hyun Hoon Chung, Jae-Weon Kim, Noh Hyun Park, Yong-Sang Song
Cancer Res Treat.2020;52(4):1229-1241.   Published online 2020 July 27     DOI: http://dx.doi.org/10.4143/crt.2020.557
      
3 Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
Jaeeun Yoo, Gun Dong Lee, Jee Hae Kim, Seung Nam Lee, Hyojin Chae, Eunhee Han, Yonggoo Kim, Myungshin Kim
Ann Lab Med.2020;40(2):148-154.   Published online 2019 October 23     DOI: http://dx.doi.org/10.3343/alm.2020.40.2.148
      
4 Usage Patterns of Surveillance, Chemoprevention and Risk-Reducing Surgery in Korean BRCA Mutation Carriers: 5 Years of Experience at a Single Institution
Do Hoon Koo, Il Yong Chung, Eunyoung Kang, Sang Ah Han, Sung-Won Kim
J Breast Cancer.2011;14(Suppl 1):S17-S23.   Published online 2011 February 28     DOI: http://dx.doi.org/10.4048/jbc.2011.14.S.S17
      
5 The Prevalence of Ovarian Cancer in Korean Women at High-Risk for Hereditary Breast-Ovarian Cancer
Jihyoun Lee, Eunyoung Kang, Sung-Won Kim, Boyoung Park, Sue K. Park, Sei-Hyun Ahn, Hy-De Lee, Joon Jeong, Sung Hoo Jung, Byoung Kil Lee, Myung Chul Chang, Young Tae Bae, Young Up Cho, Ki-Tae Hwang, Hyun-Ah Kim, Eun-Kyu Kim, Nam Sun Paik, Sehwan Han, Chan Seok Yoon, Min Hyuk Lee,
J Breast Cancer.2011;14(Suppl 1):S24-S30.   Published online 2011 February 28     DOI: http://dx.doi.org/10.4048/jbc.2011.14.S.S24
      
6 Gene Mutations in Animal Models: Do Tumor Suppressor Genes, brca1 and brca2, Play a Role in Ovarian Carcinogenesis?
Bo-Rim Yi, Kyung-A Hwang, Kyung-Chul Choi
Lab Anim Res.2010;26(4):323-330.   Published online 2010 January 20     DOI: http://dx.doi.org/10.5625/lar.2010.26.4.323
   

 1 of 1